Statins fail to reduce mortality rate in sepsis patients with ARDS

(Medical College of Wisconsin) Despite previously-reported observational and basic science evidence suggesting the use of statins may improve outcomes in patients with sepsis and acute respiratory distress syndrome, a double-blinded clinical trial of rosuvastatin in those patients was futile, and the study was halted.